Alina Cocuzza

Executive Director and Head, External Affairs at Lexicon

Role: Executive Director and Head, External Affairs at Lexicon Pharmaceuticals, Inc.
Location: Randolph, NJ, US
LinkedIn followers: 500 followers

Advertising & MarketingView LinkedIn profile

About Alina Cocuzza

Pharm.D. External Affairs professional with extensive global pharmaceutical industry experience. Focus on impactful relationship building and significant reach for business-critical milestones. Product launch leadership with unique expertise in capability building and creative solutions. Consistent successful execution of strategy with flexibility to pivot as business priorities dictate.

Experience

Executive Director and Head, External Affairs
Lexicon Pharmaceuticals, Inc.
Jul 2025 — Present · Bridgewater, NJ, US

Education

Rutgers University
Bachelor of Science (B.S.), Business Administration and Management, General
2004 — 2008
Rutgers University School of Pharmacy
Doctor of Pharmacy (PharmD), Pharmacy
2012 — 2016

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@lexpharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Lexicon Pharmaceuticals, Inc.

Pharmaceutical Manufacturing · 280 employees · Founded 1995 · The Woodlands, Texas, United States

Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. The Genome: Our Source of Discovery We have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies into a systematic drug discovery and development process. Our unique knowledge of targets from the human genome has allowed us to better evaluate and advance novel drug candidates with great promise for patients. A Diverse Pipeline of Targeted Therapies Our genomics-based approach to drug discovery has enabled our scientists to select drug targets across a broad range of indications with high unmet medical need. All of our drug candidates are new molecular entities discovered internally by our dedicated drug discovery teams and designed to affect particular points on a genetically-defined pathway that can be used to fight a disease process. We have advanced new therapies across a wide spectrum of human disease, from conditions affecting millions of people, such as diabetes, to carcinoid syndrome, an orphan cancer indication with few treatment options.

lexpharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Alina Cocuzza

Experience

Executive Director and Head, External Affairs

Education

Rutgers University

Rutgers University School of Pharmacy

Find verified contacts for anyone on LinkedIn